Genomind, LLC
Genomind is dedicated to advancing personalized medicine through pharmacogenetics (PGx) and innovative health technology solutions. Founded over a decade ago by Dr. Ronald Dozoretz, the company aims to bring genetic insights to mental health treatment, reducing trial and error, and improving patient outcomes. Their comprehensive platform supports clinicians and individuals with tools for genetic testing, software for evaluating gene-drug interactions, and expert consultations, all designed to optimize medication management and mental health care.
Industries
Nr. of Employees
medium (51-250)
Genomind, LLC
2200 Renaissance Blvd Ste 100, King of Prussia, PA 19406
Patents
Products
Clinical pharmacogenetic assay (multi-gene panel)
Clinician-ordered genotyping assay using buccal sample collection to detect variants across a defined set of genes relevant to medication metabolism and response.
Clinical decision support software for pharmacogenetics
Web/cloud-based software that integrates genetic results with medication lists to identify gene–drug and drug–drug interactions and provide prescribing recommendations.
Clinical pharmacogenetic assay (multi-gene panel)
Clinician-ordered genotyping assay using buccal sample collection to detect variants across a defined set of genes relevant to medication metabolism and response.
Clinical decision support software for pharmacogenetics
Web/cloud-based software that integrates genetic results with medication lists to identify gene–drug and drug–drug interactions and provide prescribing recommendations.
Services
Laboratory service that performs multi-gene genotyping assays on clinician-ordered buccal samples to inform medication selection and dosing.
Cloud/web-based software that analyzes genetic results alongside medication lists to flag potential gene–drug and drug–drug interactions and provide actionable recommendations within clinical workflows.
Remote consults with licensed clinical pharmacology experts to assist with report interpretation, provider education, and complex case support.
Analytics service that integrates with customer data and EHRs to identify high-risk patients, prioritize testing candidates, and estimate potential clinical and financial impacts.
Creation and distribution of patient-facing articles, guides, and clinician educational materials covering pharmacogenetics, medication adherence, risk stratification, and related clinical topics.
Laboratory service that performs multi-gene genotyping assays on clinician-ordered buccal samples to inform medication selection and dosing.
Cloud/web-based software that analyzes genetic results alongside medication lists to flag potential gene–drug and drug–drug interactions and provide actionable recommendations within clinical workflows.
Remote consults with licensed clinical pharmacology experts to assist with report interpretation, provider education, and complex case support.
Analytics service that integrates with customer data and EHRs to identify high-risk patients, prioritize testing candidates, and estimate potential clinical and financial impacts.
Creation and distribution of patient-facing articles, guides, and clinician educational materials covering pharmacogenetics, medication adherence, risk stratification, and related clinical topics.
Expertise Areas
- Pharmacogenetic testing and interpretation
- Clinical decision support for medication safety
- Population health analytics for medication risk stratification
- Clinical laboratory testing under CLIA/CAP with state licensing
Key Technologies
- Multi-gene pharmacogenetic genotyping panels
- Clinical decision support systems (CDSS) for gene–drug and drug–drug interactions
- Secure cloud-based reporting portals for clinicians and patients
- EHR/EMR integration interfaces
News & Updates
Genomind’s new partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.
Genomind announces the release of its innovative patient report that provides an easy-to-understand view into personalized genetic test results.
An integrated platform to reduce polypharmacy errors that cost lives and billions of dollars annually.
Addressing a significant public health burden with innovative approaches.
Providers can now order Genomind testing and view results within their Epic EHR system.
Empowering clinicians with genetic insights to reduce polypharmacy errors.
Genomind’s new partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.
Genomind announces the release of its innovative patient report that provides an easy-to-understand view into personalized genetic test results.
An integrated platform to reduce polypharmacy errors that cost lives and billions of dollars annually.
Addressing a significant public health burden with innovative approaches.
Providers can now order Genomind testing and view results within their Epic EHR system.
Empowering clinicians with genetic insights to reduce polypharmacy errors.